ABIO - ARCA biopharma, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.2-0.2-0.95-0.95
Low Estimate-0.2-0.2-0.95-0.95
High Estimate-0.2-0.2-0.95-0.95
Year Ago EPSN/AN/A-1.77-0.95
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryInvalid DateInvalid DateInvalid Date12/30/2017
EPS Est.N/AN/AN/A-0.52
EPS ActualN/AN/AN/A-0.34
DifferenceN/AN/AN/A0.18
Surprise %N/AN/AN/A34.60%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.2-0.2-0.95-0.95
7 Days Ago-0.2-0.2-0.95-0.95
30 Days Ago-0.22-0.22-10
60 Days Ago004.340
90 Days Ago004.340
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days111N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesABIOIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.42
Next Qtr.N/AN/AN/A0.38
Current Year46.30%N/AN/A0.20
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A